Health Economics›Prostate cancer›Salvage ADT and radiotherapy

Salvage ADT and radiotherapy

Prostate cancer · 3 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
Bicalutamide and RT Variant #01	—	R 1 396	49d	—	—	—	—	1
Goserelin and RT Variant #01	—	R 584	90d	—	—	—	—	1
ADT and RT Variant #01 Partial	—	—	56d	—	~105.8 mo	—	—	3

3 of 3 regimens shown